Pretax income is the income that a company earns before paying income taxes. Lucid Diagnostics's pretax income for the
three
months ended in Mar. 2024 was $-10.61 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-47.03 Mil.
Lucid Diagnostics's pretax margin was -1,060.14%.
During the past 5 years, Lucid Diagnostics's highest Pretax Margin was -1576.63%. The lowest was -14899.47%. And the median was -5615.60%.
Lucid Diagnostics Pre-Tax Income Historical Data
The historical data trend for Lucid Diagnostics's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lucid Diagnostics's Pre-Tax Income
For the Medical Devices subindustry, Lucid Diagnostics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lucid Diagnostics's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lucid Diagnostics's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Lucid Diagnostics's Pre-Tax Income falls into.
Lucid Diagnostics Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Lucid Diagnostics's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-47.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lucid Diagnostics (NAS:LUCD) Pre-Tax Income Explanation
Lucid Diagnostics's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 5 years, Lucid Diagnostics's highest Pretax Margin was -1576.63%. The lowest was -14899.47%. And the median was -5615.60%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lucid Diagnostics Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Lucid Diagnostics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Lucid Diagnostics (Lucid Diagnostics) Business Description
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LUCD has been successfully added to your 